Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (4904)	11/27/1997 4:40:00 AM
From: Tharos	Respond to of 17367

Geoge, Was not questioning your opinion on whether or not it was a good play, just commenting that with professional experience it should be easy to understand playing both sides of the fence. Thanks for the link. Yamaichi still in the headlines here. Today an employee (in Osaka I think) jumped off of their building, landing in front of the front door. Also in news is ex-Daiwa Securities employees that paid off a mobster, used the similar scam that netted Hilary Clinton 100K but in this case the dollar value is in the millions.

To: aknahow who wrote (4904)	11/27/1997 10:08:00 AM
From: Robert K.	Read Replies (2) \| Respond to of 17367

I have to agree with George again. Most investors dont realize xoma gets royalties. Regarding IDEC.....My personal guess is not to worry about future competition, and remember ramp-up time needed. I would guess perhaps 100 mil sales in 98 and 200 mil in 99. (I hate High estimates) I think 2% is reasonable, thats 2 mil then 4 mil. I think that would be the low end. Most probable is 4-8 mil in 99 IMO. Thats 25% of yearly expenses. Thats a lot. Then cd11a is anothr 8 mil, thats another 25% Then there is connetics, diagnostics, production lisc. royalties ,etc. downstream. All in all thats the underlying foundation. If/when we add a bpi deal then that completes the picture. Regarding bpi results from all the trials I think it paints a confusing picture to some. There is some data, some results. The potential is there. I think bpi molecule is a key player, yet they seem to be missing something. IMO we should be getting more solid results from the molecule(not that the results arnt good,just not a blowout)) Perhaps the lbp assay will solve that. Dont know. I dont know how they will solve the mystery, but if they do its the jackpot. In the meantime we certainly have lots to hope for with all the trials. Happy Thanksgiving to all..................... .